
Avicanna
A Toronto, Canada-based biotechnology company focused on the research, development and commercialization of plant-derived cannabinoid-based products.
Market cap
$24.2m
Enterprise value
$24m
Share price
CAD0.28 AVCN.TO
Authorizing premium user...